Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action

1. The topoisomerase II inhibitor amsacrine is used in the treatment of acute myelogenous leukemia. Although most anticancer drugs are believed not to cause acquired long QT syndrome (LQTS), concerns have been raised by reports of QT interval prolongation, ventricular fibrillation and death associat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Thomas, Dierk, Hammerling, Bettina C, Wu, Kezhong, Wimmer, Anna-Britt, Ficker, Eckhard K, Kirsch, Glenn E, Kochan, Mary C, Wible, Barbara A, Scholz, Eberhard P, Zitron, Edgar, Kathöfer, Sven, Kreye, Volker A W, Katus, Hugo A, Schoels, Wolfgang, Karle, Christoph A, Kiehn, Johann
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2004
Aiheet:
Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1574964/
https://ncbi.nlm.nih.gov/pubmed/15148258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705795
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia